🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this trial is to assess the effects of cytisinicli...
Status
Completed
Location
BlueClinical Phase I
Start Date
2022-10-17
Trial ID
NCT05566288
Treatments Being Tested
Compare the effect of exenatide (therapeutic and supratherapeutic concentra...
Status
Completed
Location
Research Site
Start Date
2011-02
Trial ID
NCT01297062
Treatments Being Tested
The study will investigate whether administration of clazosentan can affect...
Status
Completed
Location
QPS Netherlands B.V.
Start Date
2018-09-18
Trial ID
NCT03657446
Treatments Being Tested
The main objective of this trial is to evaluate the effects of a single the...
Status
Completed
Location
Quotient Sciences
Start Date
2024-03-06
Trial ID
NCT06107036
Treatments Being Tested
The effect of multiple oral administration of two doses of CG5503 PR (prolo...
Status
Completed
Location
DE001 - Contract research organisation
Start Date
2003-03
Trial ID
NCT03951402
This study is being performed to investigate the potential for AZD5672 to a...
Status
Completed
Location
Research Site
Start Date
2009-04
Trial ID
NCT00887770
The purpose of this study is to determine whether BMS-791325 has an effect ...
Status
Completed
Location
Ppd Development, Llc
Start Date
2014-04
Trial ID
NCT02084953
Treatments Being Tested
A study to determine the cardiovascular effects of PF00610335 in healthy vo...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-06
Trial ID
NCT01107054
Treatments Being Tested
This is a study designed to ascertain the effect of PF-04447943 on QT inter...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2016-06-29
Trial ID
NCT02785770
Treatments Being Tested
To demonstrate that tiotropium (Spiriva®) does not prolong the QT interval ...
Status
Completed
Location
Humanpharmakologisches Zentrum
Start Date
2004-10
Trial ID
NCT00257452
Treatments Being Tested